Trypacidin
Based on 1 Customer Validation
Trypacidin is the conidia-bound metabolite with antiprotozoal activity. Trypacidin has a protective function against phagocytes both in the environment and during the infection process.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.9%
- CAS No.: 1900-29-4
- 화학식: C18H16O7
- 분자량:344.32
-
보관:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocol
- 순도&문서
- References
-
Help & FAQs
-
HY-134161
DL-α-(Difluoromethyl)arginineArginine Decarboxylases Inhibitor -
HY-B0413S
Fenbendazole-d3Stable Isotope -
HY-124452
NocardamineSiderophore -
HY-N7536
VoacangineTRPM8 Antagonist -
HY-126571
Virustomycin AAntitrypanosomal Agent -
HY-124301
Penicolinate APicolinic Acid Derivative -
HY-113784
ThiocarlideAntibacterial Agent -
HY-130743
Dieugenol -
HY-N8280
IKD-8344Macrocyclic Dilactone -
HY-N9477
Betulinic aldehyde oximeAntimicrobial Agent -
HY-N12231
Carbazomycin BBacterial Metabolite -
HY-N8470
Steffimycin BBacterial Metabolite
All Parasite Isoforms
More
Biological Activity
제품 설명
Chemical Information
-
CAS No. 1900-29-4
-
Appearance Solid
-
분자량 344.32
-
화학식 C18H16O7
-
Color Off-white to light yellow
-
SMILES
O=C(C(C12OC3=CC(C)=CC(OC)=C3C1=O)=CC(C=C2OC)=O)OC
-
Structure Classification
-
Initial Source
Aspergillus fumigatus
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocol
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
순도&문서
-
Data Sheet (273 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Trypacidin Related Classifications
HY-N10255 Related Classifications
Powered by Bioz